Name of applicant:
|
GlaxoSmithKline plc
|
|||
Name of scheme:
|
GlaxoSmithKline plc 2009 Deferred Annual Bonus Plan
|
|||
Period of return:
|
From:
|
1 November 2018
|
To:
|
30 April 2019
|
Balance of unallotted securities under scheme(s) from previous
return:
|
547,331
|
|||
Plus: The amount by
which the block scheme(s) has been increased since the date of the
last return (if any increase has been applied
for):
|
0
|
|||
Less: Number
of securities issued/allotted under scheme(s) during
period (see LR3.5.7G):
|
393,607
|
|||
Equals: Balance
under scheme(s) not yet issued/allotted at end of
period:
|
153,724
|
|||
|
||||
Name of contact:
|
Victoria Whyte
|
|||
Telephone number of contact:
|
020 8047 5000
|
Name of applicant:
|
GlaxoSmithKline plc
|
|||
Name of scheme:
|
GlaxoSmithKline Share Option Plan - Ordinary Shares
|
|||
Period of return:
|
From:
|
1 November 2018
|
To:
|
30 April 2019
|
Balance of unallotted securities under scheme(s) from previous
return:
|
2,223,352
|
|||
Plus: The amount by
which the block scheme(s) has been increased since the date of the
last return (if any increase has been applied
for):
|
0
|
|||
Less: Number
of securities issued/allotted under scheme(s) during
period (see LR3.5.7G):
|
958,344
|
|||
Equals: Balance
under scheme(s) not yet issued/allotted at end of
period:
|
1,265,008
|
|||
|
||||
Name of contact:
|
Victoria Whyte
|
|||
Telephone number of contact:
|
020 8047 5000
|
Name of applicant:
|
GlaxoSmithKline plc
|
|||
Name of scheme:
|
GlaxoSmithKline Share Option Plan - ADS
|
|||
Period of return:
|
From:
|
1 November 2018
|
To:
|
30 April 2019
|
Balance of unallotted securities under scheme(s) from previous
return:
|
7,336,096
|
|||
Plus: The amount by
which the block scheme(s) has been increased since the date of the
last return (if any increase has been applied
for):
|
0
|
|||
Less: Number
of securities issued/allotted under scheme(s) during
period (see LR3.5.7G):
|
1,424,800
|
|||
Equals: Balance
under scheme(s) not yet issued/allotted at end of
period:
|
5,911,296
|
|||
|
||||
Name of contact:
|
Victoria Whyte
|
|||
Telephone number of contact:
|
020 8047 5000
|
Name of applicant:
|
GlaxoSmithKline plc
|
|||
Name of scheme:
|
GlaxoSmithKline plc Share Save Plan 2012
|
|||
Period of return:
|
From:
|
1 November 2018
|
To:
|
30 April 2019
|
Balance of unallotted securities under scheme(s) from previous
return:
|
5,672,623
|
|||
Plus: The amount by
which the block scheme(s) has been increased since the date of the
last return (if any increase has been applied
for):
|
0
|
|||
Less: Number
of securities issued/allotted under scheme(s) during
period (see LR3.5.7G):
|
3,345,727
|
|||
Equals: Balance
under scheme(s) not yet issued/allotted at end of
period:
|
2,326,896
|
|||
|
||||
Name of contact:
|
Victoria Whyte
|
|||
Telephone number of
contact:
|
020 8047 5000
|
|
GlaxoSmithKline plc
|
|
(Registrant)
|
|
|
Date: May
13, 2019
|
|
|
|
|
By:/s/ VICTORIA
WHYTE
--------------------------
|
|
|
|
Victoria Whyte
|
|
Authorised
Signatory for and on
|
|
behalf
of GlaxoSmithKline plc
|